论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
辅酶Q在糖尿病及其常见并发症中的研究进展
Authors Xia J, Li X, Bai C, Han X
Received 6 June 2024
Accepted for publication 16 September 2024
Published 3 October 2024 Volume 2024:17 Pages 3629—3641
DOI https://doi.org/10.2147/DMSO.S481690
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Prof. Dr. Antonio Brunetti
Jingdong Xia,1,2 Xiudan Li,1,2 Chunying Bai,2 Xuchen Han1
1Affiliated Hospital of Chifeng University, Chifeng, The Inner Mongol Autonomous Region, Chifeng, People’s Republic of China; 2Key Laboratory of Research on Human Genetic Diseases at Universities of Inner Mongolia Autonomous Region, Chifeng, People’s Republic of China
Correspondence: Xuchen Han; Xiudan Li, Email hanxuchen2004@163.com; 1248337580@qq.com
Abstract: Coenzyme Q has garnered significant attention due to its potential role in enhancing cellular energy production and its antioxidant properties. We delve into the therapeutic potential of coenzyme Q in managing diabetes mellitus and its complications, highlighting its capacity to improve mitochondrial function, reduce inflammation and oxidative stress, and correct lipid profiles. Coenzyme Q has shown promise in ameliorating insulin resistance and alleviating complications such as diabetic peripheral neuropathy, kidney disease, retinopathy, and cardiomyopathy. However, its clinical application is limited by poor bio-availability. This review also provides a comprehensive overview of current therapeutic strategies for diabetes complications involving coenzyme Q, including stimulating endogenous synthesis and utilizing carrier transport systems, offering insights into mechanisms for enhancing coenzyme Q bio-availability. These findings suggest that, with improved delivery methods, coenzyme Q could become a valuable adjunct therapy in the management of diabetes mellitus.
Keywords: coenzyme Q, diabetes mellitus, diabetic complications